All Q4 FY26 results →
MM

Madhusudan Masala Ltd

Q4 FY26Food Products

MADHUSUDAN Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹219
Market cap₹219 Cr
P/E12.2
Updated3 Jul 2026
Read4 min read

What the Q4 FY26 call signalled

3 of 4 strong

RevenueStrong growth
MarginMargins slightly up
CapexCapex planned
FundraiseNo fundraise planned

The short version

- Target to achieve 30% CAGR over next 3-5 years driven by regional expansion and new product launches. - Madhusudan Masala aims for a 30% CAGR in revenue over the next 3-5 years driven by new region expansion, product launches, and increased branded sales.

From Madhusudan Masala Ltd's Q4 FY26 earnings-call transcript · updated 3 Jul 2026.

Revenue & Sales Performance

Strong growth
  • Target to achieve 30% CAGR over next 3-5 years driven by regional expansion and new product launches.
  • FY27 revenue expected to cross INR 400 crore, with confidence of reaching between INR 380-400 crore.
  • FY27 consolidated revenue projected to grow beyond INR 500 crore.
  • Branded sales to increase from 70% to 80% of total sales by the second half of FY27, improving margins.
  • Volume sales growth with addition of 100+ distributors, 10-12 super stockists, and over 75,000 retailers targeted in FY27.
  • New greenfield plant (commencing Sep 2026) will improve margin and manufacturing capacity but not directly drive revenue growth in FY27.

2 more points from Madhusudan Masala Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Madhusudan Masala Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • Madhusudan Masala is undertaking a Greenfield project in Jamnagar with a CapEx of approximately INR 16-17 crore, expected to commence production from September 2026.
  • This new plant will add 6,000 metric ton capacity, increasing combined capacity (with existing Jamnagar unit) to 12,000 metric ton from FY27.
  • The CapEx predominantly covers plant and machinery, civil construction (~INR 5.5 crore), packaging units, lab equipment, and office furniture; land is promoter-owned and excluded from CapEx.
  • Expansion plans include increasing Rajkot manufacturing facility capacity from FY28 or FY29, targeting 30,000 metric ton total production capacity long-term.

2 more points from Madhusudan Masala Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Food Products

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
2Hoac Foods
Rev 1Mar 1
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Madhusudan Masala Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript from the Madhusudan Masala Limited Q4/H2 & FY26 Post Earnings Conference Call does not explicitly mention the current or expected order book or pending orders. However, related insights include: - The company expects revenue of over INR 400 crore in FY27 and more than INR 500 crore in FY28. - They have a strong distributor and retailer network expansion plan, targeting over 75,000 retailers and 500+ distributors in FY27. - Capacity utilization is nearly 100% for existing manufacturing plants.

2 more points from Madhusudan Masala Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Madhusudan Masala Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹97 Cr, net profit ₹6 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Food Products this season

  • Mukka Proteins Ltd (Q4 FY26)

    Q4 FY26 Revenue from Operations:** ₹381.6 Cr . Key concall takeaways from Mukka Proteins Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.

  • Shri Ahimsa (Q4 FY26)

    Revenue figures (₹ in Crs) for FY: . Key concall takeaways from Shri Ahimsa Naturals Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.

  • Proventus Agro. (Q4 FY26)

    Retail sales to contribute 75% to 80% of total revenue. Key concall takeaways from Proventus Agrocom Ltd's Q4 FY26 earnings call — and how it ranks against…

  • Pajson Agro (Q4 FY26)

    Revenue growth is supported by strong repeat orders (78% from existing customers) and increased distribution. Key concall takeaways from Pajson Agro India…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Madhusudan Masala Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Madhusudan Masala Ltd Q1 FY27 results?

- Target to achieve 30% CAGR over next 3-5 years driven by regional expansion and new product launches. - Madhusudan Masala aims for a 30% CAGR in revenue over the next 3-5 years driven by new region expansion, product launches, and increased branded sales.

What is Madhusudan Masala Ltd share price analysis?

Madhusudan Masala Ltd currently shows a strong growth signal based on ranking data. The stock trades at a P/E of 12.2 with a market cap of ₹219. Investors should review the full earnings analysis for detailed insights.

Is Madhusudan Masala Ltd planning capital expenditure?

- Madhusudan Masala is undertaking a Greenfield project in Jamnagar with a CapEx of approximately INR 16-17 crore, expected to commence production from September 2026.

Keep Madhusudan Masala Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.